Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/183270
Full metadata record
DC FieldValueLanguage
dc.contributor.authorde Ruiter, Ruben D.-
dc.contributor.authorSmilde, Bernard J.-
dc.contributor.authorPals, Gerard-
dc.contributor.authorBravenboer, Nathalie-
dc.contributor.authorKnaus, Petra-
dc.contributor.authorSchoenmaker, Ton-
dc.contributor.authorBotman, Esmée-
dc.contributor.authorSanchez Duffhues, Gonzalo-
dc.contributor.authorPacifici, Maurizio-
dc.contributor.authorPignolo, Robert J.-
dc.contributor.authorShore, Eileen M.-
dc.contributor.authorVan Egmond, Marjolein-
dc.contributor.authorVan Oosterwyck, Hans-
dc.contributor.authorKaplan, Frederick S.-
dc.contributor.authorHsiao, Edward C.-
dc.contributor.authorYu, Paul B.-
dc.contributor.authorBocciardi, Renata-
dc.contributor.authorDe Cunto, Carmen Laura-
dc.contributor.authorRibeiro Delai, Patricia Longo-
dc.contributor.authorVries, Teun J de-
dc.contributor.authorHilderbrandt, Susanne-
dc.contributor.authorJaspers, Richard T.-
dc.contributor.authorKeen, Richard-
dc.contributor.authorKoolwijk, Peter-
dc.contributor.authorMorhart, Rolf-
dc.contributor.authorNetelenbos, Jan C.-
dc.contributor.authorRustemeyer, Thomas-
dc.contributor.authorScott, Christiaan-
dc.contributor.authorStockklausner, Clemens-
dc.contributor.authorTen Dijke, Peter-
dc.contributor.authorTriffit, James-
dc.contributor.authorVentura Pujol, Francesc-
dc.contributor.authorRavazzolo, Roberto-
dc.contributor.authorMicha, Dimitra-
dc.contributor.authorEekhoff, Elisabeth M. W.-
dc.date.accessioned2022-02-17T19:27:40Z-
dc.date.available2022-02-17T19:27:40Z-
dc.date.issued2021-11-10-
dc.identifier.issn1664-2392-
dc.identifier.urihttp://hdl.handle.net/2445/183270-
dc.description.abstractFibrodysplasia ossificans progressiva (FOP) is an ultra-rare progressive genetic disease effecting one in a million individuals. During their life, patients with FOP progressively develop bone in the soft tissues resulting in increasing immobility and early death. A mutation in the ACVR1 gene was identified as the causative mutation of FOP in 2006. After this, the pathophysiology of FOP has been further elucidated through the efforts of research groups worldwide. In 2015, a workshop was held to gather these groups and discuss the new challenges in FOP research. Here we present an overview and update on these topics.-
dc.format.extent8 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherFrontiers Media-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fendo.2021.732728-
dc.relation.ispartofFrontiers In Endocrinology, 2021, vol. 12-
dc.relation.urihttps://doi.org/10.3389/fendo.2021.732728-
dc.rightscc-by (c) de Ruiter, Ruben D. et al., 2021-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Ciències Fisiològiques)-
dc.subject.classificationMiositis-
dc.subject.classificationOssificació-
dc.subject.classificationMúsculs-
dc.subject.classificationInflamació-
dc.subject.otherMyositis-
dc.subject.otherOssification-
dc.subject.otherMuscles-
dc.subject.otherInflammation-
dc.titleFibrodysplasia Ossificans Progressiva: what have we achieved and where are we now? follow-up to the 2015 Lorentz Workshop-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec719267-
dc.date.updated2022-02-17T19:27:40Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid34858325-
Appears in Collections:Articles publicats en revistes (Ciències Fisiològiques)

Files in This Item:
File Description SizeFormat 
719267.pdf1.02 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons